Zobrazeno 1 - 10
of 24
pro vyhledávání: '"бедаквилин"'
Autor:
A. I. Gayda, A. V. Abramchenko, M. I. Romanova, T. V. Toichkina, V. S. Burykhin, S. E. Borisov, A. V. Filippov, T. A. Kuznetsova, D. V. Perkhin, O. M. Sveshnikova, M. V. Lekhlyayder, A. M. Panteleev, S. V. Toinova, T. I. Maslennikova, D. O. Galakhova, L. N. Populyashina, G. I. Saenko, E. S. Anisimova, A. K. Svicharskaya, N. A. Sosova, O. V. Lovacheva, A. O. Maryandyshev, A. G. Samoylova
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 12, Pp 44-53 (2023)
The objective: to justify the optimal duration of chemotherapy with Lzd and Bdq by evaluating the long-term treatment outcomes in patients with multiple/pre-extensive drug resistant (MDR/preXDR) tuberculosis who interrupted treatment at different tim
Externí odkaz:
https://doaj.org/article/f351e9604c4949d6bfd983a255c59acd
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 9, Pp 40-45 (2022)
The objective: to evaluate safety and efficacy of bedaquiline in the treatment of patients with multiple drug resistant tuberculosis (MDR-TB).Subjects and Methods. Clinical data of 523 patients above 18 years old registered for MDR TB treatment as pe
Externí odkaz:
https://doaj.org/article/325e662d08c5410cb51250b8b5d62b83
Autor:
A. A. Starshinova, M. M. Nazarenko, E. N. Belyaeva, D. A. Kudlay, M. V. Pavlova, P. K. Yablonskiy
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 5, Pp 56-63 (2022)
The objective: to compare treatment efficacy of pulmonary tuberculosis patients with multiple (MDR) and extensive drug resistance (XDR) using a standard chemotherapy regimen and the regimen containing bedaquiline.Subjects and Methods. A retrospective
Externí odkaz:
https://doaj.org/article/ca25bff249f542ac901551559ffe3cb1
Publikováno v:
Туберкулез и болезни лёгких, Vol 100, Iss 5, Pp 35-40 (2022)
The objective: to evaluate the efficacy and safety of various anti-tuberculosis therapy regimens for multiple drug resistant (MDR) and extensive drug resistant pulmonary tuberculosis in the intensive phase of treatment lasting for 8 months minimum.Su
Externí odkaz:
https://doaj.org/article/d11159fda4b04c9c8515786bbfa6ca56
Publikováno v:
Туберкулез и болезни лёгких, Vol 99, Iss 10, Pp 35-39 (2021)
The objective of the study: to evaluate the efficacy and safety of short course chemotherapy regimens for multiple/extensive drug resistant tuberculosis of the respiratory system (MDR/XDR) in older children and adolescents.Subjects and Methods. A coh
Externí odkaz:
https://doaj.org/article/811c77d3ca4a45299f418cf2a1581b82
Publikováno v:
Туберкулез и болезни лёгких, Vol 99, Iss 8, Pp 47-53 (2021)
The article describes a clinical case of the treatment of a young child with a complicated course of tuberculosis with multiple localizations and concurrent primary immunodeficiency. The new anti-tuberculosis drug of bedaquiline was successfully used
Externí odkaz:
https://doaj.org/article/7b243d7e13704876b57a46f05a15a357
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 12, Pp 57-66 (2021)
The article presents a review of 70 publications. It describes relevant data on drugs, timing, indications, efficacy, and safety of short-term treatment regimens for multiple drug resistant tuberculosis.
Externí odkaz:
https://doaj.org/article/ea887e4bbcc048a8bb8d545a1390406c
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 9, Pp 56-62 (2020)
The effectiveness of tuberculosis control is associated with efficacy of treatment of TB patients and above all patients with multiple and extensive drug resistance (MDR/XDR MTB). Patients with TB/HIV co-infection providethe significant impact on the
Externí odkaz:
https://doaj.org/article/b6ff9258b7064dec8665460eb1bcf808
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 7, Pp 56-62 (2020)
The objective of the study: to perform the multivariate analysis of treatment outcomes in patients with multiple/extensive drug resistant tuberculosis (MDR/XDR TB), including those with HIV infection, whose chemotherapy regimens included bedaquiline.
Externí odkaz:
https://doaj.org/article/6f4bc3f16a9141cd816698f93e3d9245
Autor:
P. N. Golubchikov, D. Yu. Schegertsov, T. I. Melnikovа, D. V. Krаsnov, D. A. Skvortsov, N. G. Grischenko
Publikováno v:
Туберкулез и болезни лёгких, Vol 98, Iss 6, Pp 52-59 (2020)
The article describes a clinical case of successful treatment of a patient with disseminated bilateral fibrous cavernous tuberculosis and extensive drug resistance, with preserved sensitivity to only one anti-tuberculosis drug; the fifth chemotherapy
Externí odkaz:
https://doaj.org/article/612b622f3fdf4bc2b94b78c4e11fdd0a